RAQUEL BERTOLOTTI: Open Payments
NPI 1710692074 · EAST GREENWICH, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,259 in 202 payments from 15 companies in 2025. Trend: 2023 $5,066 · 2024 $3,632 · 2025 $4,259
Food & beverage: $4,159Education: $100
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 71 | $1,367 |
| ABBVIE INC. | 45 | $658 |
| LEO Pharma Inc. | 24 | $503 |
| Novartis Pharmaceuticals Corporation | 17 | $425 |
| Galderma Laboratories, L.P. | 10 | $412 |
| UCB, Inc. | 7 | $242 |
| Regeneron Healthcare Solutions, Inc. | 8 | $229 |
| Amgen Inc. | 2 | $93 |
| GENZYME CORPORATION | 4 | $76 |
| E.R. Squibb & Sons, L.L.C. | 4 | $68 |
Products named: TREMFYA, ADBRY, SKYRIZI, NEMLUVIO, RINVOQ, DUPIXENT, Bimzelx, Rhapsido.
Industry payments across RI — which companies pay providers there.
